MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,689 | -4.8% | 67,918 | -0.2% | 0.05% | -10.0% |
| Q1 2023 | $16,479 | -68.2% | 68,025 | -61.9% | 0.06% | -67.7% |
| Q4 2022 | $51,814 | -99.8% | 178,518 | +93.6% | 0.19% | +148.0% |
| Q2 2018 | $25,785,000 | +266.7% | 92,193 | +53.1% | 0.08% | +257.1% |
| Q1 2018 | $7,031,000 | -25.1% | 60,200 | -41.1% | 0.02% | -22.2% |
| Q4 2017 | $9,384,000 | – | 102,242 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |